Causaly

About:

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

Twitter/X: CausalyAI

Top Investors: ICONIQ Growth, Index Ventures, EBRD Venture Capital, Charlie Songhurst, Emerge

Description:

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine. It amplifies human cognitive abilities to expand the boundaries of discovery toward making the best decisions in biomedicine.

Total Funding Amount:

$93M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2018-01-01

Founders:

Artur Saudabayev, Yiannis Kiachopoulos

Number of Employees:

101-250

Last Funding Date:

2023-07-13

IPO Status:

Private

Industries: